We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLXE icon
1826
KLX Energy Services
KLXE
$42.3M
$48K ﹤0.01%
1,126
+1,058
+1,556% +$70.5K
LNN icon
1827
Lindsay Corp
LNN
$1.18B
$48K ﹤0.01%
+518
New +$46.2K
MRUS
1828
DELISTED
Merus
MRUS
$48K ﹤0.01%
+2,692
New +$44.2K
PCH
1829
DELISTED
PotlatchDeltic
PCH
$48K ﹤0.01%
1,168
+135
+13% +$5.24K
RGR icon
1830
Sturm, Ruger & Co
RGR
$593M
$48K ﹤0.01%
1,144
+868
+314% +$40.6K
SBRA icon
1831
Sabra Healthcare REIT
SBRA
$5.37B
$48K ﹤0.01%
2,121
-623
-23% -$13.3K
UFPT icon
1832
UFP Technologies
UFPT
$2.43B
$48K ﹤0.01%
+1,246
New +$51.2K
AMBA icon
1833
Ambarella
AMBA
$3.81B
$47K ﹤0.01%
751
+403
+116% +$20.9K
ARVN icon
1834
Arvinas
ARVN
$572M
$47K ﹤0.01%
+2,194
New +$53.8K
BSAC icon
1835
Banco Santander Chile
BSAC
$16.6B
$47K ﹤0.01%
1,681
-661
-28% -$19.1K
CSL icon
1836
Carlisle Companies
CSL
$15.4B
$47K ﹤0.01%
323
-550
-63% -$77.3K
FBIZ icon
1837
First Business Financial Services
FBIZ
$595M
$47K ﹤0.01%
1,949
+1,849
+1,849% +$43.5K
MEOH icon
1838
Methanex
MEOH
$4.12B
$47K ﹤0.01%
1,310
-2,194
-63% -$81.1K
PGC icon
1839
Peapack-Gladstone Financial
PGC
$812M
$47K ﹤0.01%
+1,685
New +$47.3K
SRPT icon
1840
Sarepta Therapeutics
SRPT
$1.77B
$47K ﹤0.01%
+625
New +$73.8K
URGN icon
1841
UroGen Pharma
URGN
$2.29B
$47K ﹤0.01%
2,000
+1,875
+1,500% +$61.3K
VAC icon
1842
Marriott Vacations Worldwide
VAC
$4.25B
$47K ﹤0.01%
457
-3,438
-88% -$338K
WHG icon
1843
Westwood Holdings Group
WHG
$190M
$47K ﹤0.01%
+1,706
New +$51.8K
JBTM
1844
JBT Marel
JBTM
$6.39B
$47K ﹤0.01%
470
-986
-68% -$109K
IVC
1845
DELISTED
Invacare Corporation
IVC
$47K ﹤0.01%
+6,270
New +$35.2K
PFBI
1846
DELISTED
Premier Financial Bancorp
PFBI
$47K ﹤0.01%
2,734
+2,693
+6,568% +$42.7K
BID
1847
DELISTED
Sotheby's
BID
$47K ﹤0.01%
814
-1,086
-57% -$62.9K
BSBR icon
1848
Santander
BSBR
$43.5B
$46K ﹤0.01%
4,412
-4,666
-51% -$49.8K
CASY icon
1849
Casey's General Stores
CASY
$30.9B
$46K ﹤0.01%
288
-272
-49% -$44.8K
CYCN icon
1850
Cyclerion Therapeutics
CYCN
$16.7M
$46K ﹤0.01%
189
+68
+56% +$14.7K

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.